However, neither RSL3 nor erastin elicited histological epidermal changes or immune cell infiltration in the skin characteristic of psoriasis, while skin TNF-α and IL-1β expressions were elevated by RSL3 treatment (Supplemental Figure 2, E and F, and Supplemental Figure 3, A–D). The gene discussed is IL1B; the disease is psoriasis.